Back to results
CompletedPhase 3

Study of Rivoglitazone in Type 2 Diabetes Mellitus

NCT00484198

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Anniston, Alabama, United States

+182 additional locations

View on ClinicalTrials.gov